Printed from https://fyi.org.nz/request/32733-kostaive-self-amplifying-mrna-in-new-zealand on November 05, 2025 02:45

We don't know whether the most recent response to this request contains information or not – if you are John Armstrong please sign in and let everyone know.

Kostaive self-amplifying mRNA in New Zealand

John Armstrong made this Official Information request to Pharmaceutical Management Agency

This request has an unknown status. We're waiting for John Armstrong to read a recent response and update the status.

From: John Armstrong

Dear Pharmaceutical Management Agency,

I seek information for Kostaive self-amplifying mRNA as listed on pg 10, section 8 - Market Analysis, in a prior response received from Pharmac, reference H2025072586, Procurement Plan for Covid-19 vaccine RFP.
https://fyi.org.nz/request/32255-supply-...

It states: "Pharmac staff are aware of four Covid-19 vaccines that may be available in New Zealand". These were then listed as follows:
1/ Kostaive (Seqirus) self-amplifying mRNA.
2/ Spikevax (Moderna) mRNA
3/ Comirnaty (Pfizer) mRNA
4/ Nuvaxovid (Biocelect /Novavax) attenuated protein subunit

Q1/ Is Kostaive currently in circulation and being administered in NZ?
Q2/ Has Kostaive been administered in the past in NZ, please provide dates?
Q3/ Please supply documentation of clinical trials for Kostaive in NZ?
Q4/ Please supply Medsafe's approval and consent for distribution of Kostaive in NZ.

Yours faithfully,

John Armstrong

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Thank you for contacting Pharmac, we have received your enquiry and will
endeavour to have a reply to you as soon as we can.

 

Pharmac cannot provide medical advice. If you have questions about your
health or are experiencing side effects from medicines, please call:

·        Your usual healthcare provider.

·         Healthline on 0800 611 116.

·         111 for medical emergencies. 
This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.

Link to this

We don't know whether the most recent response to this request contains information or not – if you are John Armstrong please sign in and let everyone know.

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: